TrialJournal of diabetes investigation2018

Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study.

Soichi Takeishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.